While employer-sponsored health benefits are not likely to disappear, changes that shift financial risk to employees are certain.
According to Deloitte, U.S. employers are concerned about continued rising healthcare costs; however, they are unaware of solutions that could improve the safety and quality of care, and simultaneously reduce cost. While employer-sponsored health benefits are not likely to disappear, changes that shift financial risk to employees are certain, according to the company’s survey.
The survey of employers with 50+ workers offering health benefits explores employers’ opinions about the U.S. healthcare system, the Patient Protection and Affordable Care Act (PPACA), and anticipated strategies for employee health benefits coverage and cost containment.
Survey results also revealed:
35% of employers surveyed grade system performance as an “A” or a “B.” Employers hold favorable views about the system’s clinical capabilities and medical innovation, but unfavorable views center on its wastefulness and high costs.
Employers believe that they have a “good” understanding of the PPACA. Familiarity with the individual mandate is the highest (72%). Most employers say their company is “not well prepared” to implement the 2014 provisions of the ACA.
30% think the PPACA is “a good start,” 59% “a step in the wrong direction.”
To manage healthcare costs, increased cost sharing with employees is considered the optimal strategy.
When considering healthcare related strategies to reduce the deficit, employers support reforms in medical liability, Medicare and Medicaid, and repeal/delay of the PPACA. Across-the-board cuts in government spending are considered a higher priority than changes to the healthcare system.
Go back to the Managed Healthcare Executive eNews newsletter.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More